Glucocorticoid therapy as first-line treatment in primary hypophysitis: a systematic review and individual patient data meta-analysis

OBJECTIVES: High-dose glucocorticoids are associated with improved recovery of deficits in primary autoimmune hypophysitis (PAH), but optimal dosing, route, and duration are unclear. DESIGN: We reviewed literature for first-line glucocorticoid treatment in PAH until December 2021 and performed an in...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishnappa, Brijesh, Shah, Ravikumar, Memon, Saba Samad, Diwaker, Chakra, Lila, Anurag R, Patil, Virendra A, Shah, Nalini S, Bandgar, Tushar R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874965/
https://www.ncbi.nlm.nih.gov/pubmed/36445257
http://dx.doi.org/10.1530/EC-22-0311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874965/
https://www.ncbi.nlm.nih.gov/pubmed/36445257
http://dx.doi.org/10.1530/EC-22-0311

Ejemplares similares